Ethical issues in international environmental health research

International Journal of Hygiene and Environmental Health

Volumn 206, Issue 4-5, 2003, Pages 453-463

  Lavery, James V ^a,b   Upshur, R E G ^e   Sharp, R R ^c,d   Hofman, K J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e NONE

Author keywords

Environmental health; Environmental justice; Ethics; Global health

Indexed keywords

CLINICAL FEATURE; CLINICAL RESEARCH; DANGEROUS GOODS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE PREDISPOSITION; DOCUMENTATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MANAGEMENT; ENVIRONMENTAL PROTECTION; HEALTH HAZARD; HEALTH PROMOTION; HUMAN; INTERNATIONAL COOPERATION; MEDICAL ETHICS; MEDICAL RESEARCH; POLITICS; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

EID: 0043281542     PISSN: 14384639     EISSN: None     Source Type: Journal    
DOI: 10.1078/1438-4639-00242     Document Type: Article

References (66)

1. Ahlbom, A., Feychting, M.: A Bayesian approach to hazard identification. The case of electromagnetic fields and cancer. Annals of the New York Academy of Sciences. 895, 27-33 (1999).
2. Akwesasne Research Advisory Committee, Akwesasne Task Force on the Environment. Protocol for Review of Environmental and Scientific Research Proposals. Akwesasne Task Force on the Environment, Hogansburg, N. Y. 1996.
3. Benatar, S. R.: Avoiding exploitation in clinical research. Cambridge Quarterly of Healthcare Ethics. 9, 562-565 (2000).
4. Beyrer, C., Kass, N.: Human rights, politics, and reviews of research ethics. Lancet. 360, 246-51 (2002).
5. Brennan, P., Croft, P.: Interpreting the results of observational research: chance is not such a fine thing. British Medical Journal. 309, 727-30 (1994).
6. Calman, K., Smith, D.: Works in theory but not in practice? Some notes on the precautionary principle. (http://www.dcs.gla.ac.uk/johnson/papers/HECS99/Calman Smith.htm). Accessed October 12, 2002.
7. Carpenter, D. O.: Communicating with the public on issues of science and public health. Environmental Health Perspectives. 103 (Suppl 6), 127-130 (1995).
8. Christiani, D. C., Sharp, R. R., Collman, G. W., Suk, W. A.: Applying genomic technologies in environmental health research: Challenges and opportunities. Journal of Occupational and Environmental Medicine. 43 (6), 1-12 (2001).
9. Davis, D. S.: Groups, communities, and contested identities in genetic research. Hastings Center Report. 30, 38-45 (2000).
10. Department of Health and Human Services Office of Inspector General.: The Gobalization of Clinical Trials: A Growing Challenge in Protecting Human Subjects. Office of Evaluation and Inspections, Boston 2001.
11. Emanuel, E. J., Killen, J., Wendler, D., Grady, C.: What makes multinational research ethical? Manuscript in preparation, 2003.
12. Emanuel, E. J., Wendler, D., Grady, C.: What makes clinical research ethical? JAMA. 283, 2701-2711 (2000).
13. Epstein, S.: Impure Science: AIDS, Activism, and the Politics of Knowledge. University of California Press, Berkley 1996.
14. European Environment Agency. Late lessons from early warnings: the precautionary principle 1896-2000. Environment Issue Report No. 22. Official Publications of the European Communities, Luxembourg 2001.
15. Fidler, D. P.: "Geographical Morality" revisited: International relations, international law, and the controversy over placebo-controlled HIV clinical trials in developing countries. Harvard International Law Journal. 42 (2), 299-354 (2001).
16. Fluss, S.: International Guidelines on Bioethics: European Forum on Good Clinical Practice/Council of International Organizations of Medical Sciences, Geneva 1998.
17. Forster, H. P., Emanuel, E. J., Grady, C.: The 2000 revision of the Declaration of Helsinki: a step forward or more confusion? Lancet. 358, 449-53 (2001).
18. Foster, M. W., Sharp, R. R.: Genetic research and culturally specific risks: one size does not fit all. Trends in Genetics. 16, 93-95 (2000).
19. Glantz, L. H., Annas, G. J., Grodin, M. A., Mariner, W. K.: Research in developing countries: Taking "benefit" seriously. Hastings Center Report. 28 (6), 38-42 (1998).
20. Global Forum for Health Research. The 10/90 Report on Health Research 2000. Global Forum for Health Research, Geneva 2000.
21. Green, L. W., George, M. A., Daniel, M., Frankish, C. J., Herbert, C. P., Bowie, W. R., O'Neil, M.: Background on participatory research. In: Study of Participatory Research in Health Promotion: Review and Recommendations for the Development of Participatory Research in Health Promotion in Canada. The Royal Society of Canada, Ottawa 1995.
22. Greenland, S.: Randomization, statistics, and causal inference. Epidemiology 1, 421-9 (1990).
23. Grimes v. Kennedy Krieger Institute, Inc., 782 A.2d 807 (Md. 2001).
24. Harmon, Z.: World Bank, Big Oil and the Niger Delta. Virtual Caf. January 21, 1997. http://forests.org/archive/africa/nigdelta.htm (Accessed September 5, 2002).
25. Juengst, E. J.: Groups as gatekeepers to genomic research: conceptually confusing, morally hazardous and practically useless. Kennedy Institute Ethics Journal. 8, 183-200 (1998).
26. Kolata, G.: Proof: Looking for the link. New York Times, August 11, 2002, Week in Review.
27. Kristof, N. D., WuDunn, S.: Thunder from the East: Portrait of a Rising Asia. Alfred A. Knopf, New York 2000. (Chapter 13, The Filthy Earth, pp. 291-313).
28. Lavery, J. V.: A culture of ethical conduct in research: The proper goal of capacity-building in international research ethics. Working Paper WG2: 5. World Health Organization, Commission on Macroeconomics and Health. WHO, Geneva 2001.
29. Levine, R. J.: The "Best proven therapeutic method" standard in clinical trials in technologically developing countries. IRB: A Review of Human Subjects Research. 20 (1), 5-9 (1998).
30. Levine, R. J.: The need to revise the Declaration of Helsinki. New England Journal of Medicine. 341, 531-34 (1999).
31. Lie, R. K.: Ethics of placebo-controlled trials in developing nations. Bioethics. 12, 307-11 (1998).
32. Lurie, P., Wolfe, S.: Unethical trials of interventions to reduce perinatal transmission of the Human Immunodeficiency Virus in developing countries. New England Journal of Medicine. 337, 853-56 (1997).
33. Lynn, F. M.: Community-scientist collaboration in environmental research. American Behavioral Scientist. 44, 649-663 (1995).
34. Macaulay, A. C., Delormier, T., McComber, A. M., Cross, E. J., Potvin, L. P., Paradis, G., Kirby, R. L., Saad-Haddad, C., Desrosiers, S.: Participatory research with Native community of Kahnawake creates innovative code of research ethics. Canadian Journal of Public Health. 89, 105-108 (1998).
35. Macklin, R.: After Helsinki: Unresolved issues in international research. Kennedy Institute Ethics Journal. 11, 17-36 (2001).
36. McMichael, A. J.: The urban environment and health in a world of increasing globalization: issues for developing countries. Bulletin of the World Health Organization. 78 (9), 1117-1126 (2000).
37. National Bioethics Advisory Committee. Ethical and Policy Issues in International Research. NBAC, Washington, D. C. 2001.
38. National Health Council. National Commission for Research Ethics-CONEP. Rules on Research Involving Human Subjects. Resolutions Nos. 196/6 and others, paragraph IV (3e). Ministry of Health, Brazil, Brasilia 2000.
39. O'Fallon, L. R., Dearry, A.: Community-based participatory research as a tool to advance environmental health sciences. Environmental Health Perspectives. 110 (Suppl 2), 155-159 (2002).
40. Olukoya, S. Environmental Justice from the Niger Delta to the World Conference Against Racism. Corp-Watch. August 30, 2001. http://www.corpwatch.org/issues/PID.jsp?articleid=18) (Accessed September 5, 2002).
41. Oreskes, N., Shrader-Frechette, K., Belitz, N.: Verification, validation and confirmation of numerical models in the earth sciences. Science. 263, 641-646 (1994).
42. Potter, V. R.: Fragmented ethics and "Bridge bioethics". Hastings Center Report. 29 (1), 38-40 (1999).
43. Powell, D. L., Stewart, V.: Children: The unwitting target of environmental injustices. Pediatric Clinics of North America. 48 (5), 1-15 (2001).
44. Ross, L. F.: In defense of the Hopkins lead abatement studies. Journal of Law, Medicine & Ethics. 30, 50-57 (2002).
45. Schell, L. M., Tarbell, A. M.: A partnership study of PCBs and the health of Mohawk youth: lessons from our past and guidelines for our future. Environmental Health Perspectives. 106 (Suppl 3), 833-840 (1998).
46. Shapiro, H. T., Meslin, E. M.: Ethical issues in the design and conduct of clinical trials in developing countries. New England Journal of Medicine. 345, 139-142 (2001)
47. Sharp, R. R., Barrett, J. C.: The Environmental Genome Project: ethical, legal and social implications. Environmental Health Perspectives. 108, 279-281 (2000).
48. Sharp, R. R., Foster, M. W.: Community involvement in the Ethical Review of Genetic Research: Lessons from American Indian and Alaska Native Populations. Environmental Health Perspectives. 110 (Suppl 2), 145-148 (2002).
49. Sharp, R. R., Foster, M. W.: Involving study populations in the review of genetic research. Journal of Law, Medicine & Ethics. 28, 41-51 (2000).
50. Small, I., van der Meer, J., Upshur, R. E. G.: Acting on an environmental health disaster: the case of the Aral Sea. Environmental Health Perspectives. 109 (Suppl 6), 547-9 (2001).
51. Smith, K. R.: Environmental health - for the rich or for all? Bulletin of the World Health Organization. 78 (9), 1156 (2000).
52. Stolberg, S. G.: Concern among Jews is heightened as scientists deepen gene studies. New York Times, April 22, 1998: A24.
53. Sutherland, H. J., Meslin, E. M., Till, J. E.: What's missing from current clinical trial guidelines? A framework for integrating science, ethics, and the community context. The Journal of Clinical Ethics. 5 (4), 297-303 (1994).
54. The Body Hunters: Exporting Human Experiments. The Washington Post December 17-22, 2000.
55. The Maori Committee of the Health Research Council of New Zealand. Guidelines for Researchers on Health Research Involving Maori. Heath Research Council of New Zealand, Wellington 1998.
56. The Nazi Doctors and the Nuremburg Code: Human Rights in Human Experimentation (G. J. Annas, M. A. Grodin, eds.), Oxford University Press, New York 1992.
57. Weed, D. L.: Underdetermination and incommensurability in contemporary epidemiology. Kennedy Institute of Ethics Journal. 7 (2), 107-127 (1997).
58. Weijer, C., Emanuel, E. J.: Protecting communities in biomedical research. Science. 289 (5482), 1142-1144 (2000).
59. Weijer, C.: Protecting communities in research: philosophical and pragmatic challenges. Cambridge Quarterly of Healthcare Ethics. 8, 501-513 (1999).
60. Williams, M. D., Sandler, A. B.: The epidemiology of lung cancer. Cancer Treatment Research. 105, 31-52 (2001).
61. Wing, S.: Social responsibility and research ethics in community-driven studies of industrial hog production. Environmental Health Perspectives. 110 (5), 437-444 (2002).
62. Woodward, B.: Challenges to human subjects protections in U. S. medical research. JAMA. 282 (20), 1947-52 (1999).
63. World Bank. Defining an Environmental Development Strategy for the Niger Delta. Report 14266, Volume 1. World Bank, Washington, D. C. (1995).
64. World Health Organization: Global estimates of burden of disease caused by the environment. World Health Report 2002. WHO, Geneva [forthcoming].
65. World Health Organization: Health and Environment in Sustainable Development: Five Years After the Earth Summit. WHO, Geneva 1997.
66. World Medical Association. Declaration of Helsinki. World Medical Association, Geneva 2000. (www.wma.net/e/policy/7-c_e.html).